Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 4
2014 7
2015 2
2016 4
2017 5
2018 3
2019 6
2020 2
2021 2
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Individuals at risk of rheumatoid arthritis - The evolving story.
Emery P, Mankia K, Nam JL. Emery P, et al. Among authors: nam jl. Best Pract Res Clin Rheumatol. 2017 Feb;31(1):1-2. doi: 10.1016/j.berh.2017.11.003. Epub 2017 Nov 15. Best Pract Res Clin Rheumatol. 2017. PMID: 29221593 No abstract available.
Role of ultrasound imaging in individuals at risk of RA.
Nam JL, D'Agostino MA. Nam JL, et al. Best Pract Res Clin Rheumatol. 2017 Feb;31(1):71-79. doi: 10.1016/j.berh.2017.09.002. Epub 2017 Sep 27. Best Pract Res Clin Rheumatol. 2017. PMID: 29221600 Review.
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients.
Taylor JC, Bongartz T, Massey J, Mifsud B, Spiliopoulou A, Scott IC, Wang J, Morgan M, Plant D, Colombo M, Orchard P, Twigg S, McInnes IB, Porter D, Freeston JE, Nam JL, Cordell HJ, Isaacs JD, Strathdee JL, Arnett D, de Hair MJH, Tak PP, Aslibekyan S, van Vollenhoven RF, Padyukov L, Bridges SL, Pitzalis C, Cope AP, Verstappen SMM, Emery P, Barnes MR, Agakov F, McKeigue P, Mushiroda T, Kubo M, Weinshilboum R, Barton A, Morgan AW, Barrett JH; MATURA; and PAMERA; Consortia. Taylor JC, et al. Among authors: nam jl. Pharmacogenomics J. 2018 Jul;18(4):528-538. doi: 10.1038/s41397-018-0025-5. Epub 2018 May 25. Pharmacogenomics J. 2018. PMID: 29795407 Free article. Review.
Biologics in rheumatoid arthritis: where are we going?
Fechtenbaum M, Nam JL, Emery P. Fechtenbaum M, et al. Among authors: nam jl. Br J Hosp Med (Lond). 2014 Aug;75(8):448-9, 451-6. doi: 10.12968/hmed.2014.75.8.448. Br J Hosp Med (Lond). 2014. PMID: 25111096 Review.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.
Ramiro S, Sepriano A, Chatzidionysiou K, Nam JL, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, Bijlsma JW, Burmester GR, Scholte-Voshaar M, Falzon L, Landewé RBM. Ramiro S, et al. Among authors: nam jl. Ann Rheum Dis. 2017 Jun;76(6):1101-1136. doi: 10.1136/annrheumdis-2016-210708. Epub 2017 Mar 15. Ann Rheum Dis. 2017. PMID: 28298374 Review.
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Nam JL, Takase-Minegishi K, Ramiro S, Chatzidionysiou K, Smolen JS, van der Heijde D, Bijlsma JW, Burmester GR, Dougados M, Scholte-Voshaar M, van Vollenhoven R, Landewé R. Nam JL, et al. Ann Rheum Dis. 2017 Jun;76(6):1113-1136. doi: 10.1136/annrheumdis-2016-210713. Epub 2017 Mar 10. Ann Rheum Dis. 2017. PMID: 28283512 Review.
39 results